DrugPatentWatch Database Preview
Drugs in Development Information for Iclaprim
Email this page to a colleague
» See Plans and PricingWhat is the drug development status for Iclaprim?
Iclaprim is an investigational drug.
There have been 5 clinical trials for Iclaprim.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2015.
The most common disease conditions in clinical trials are Infection, Soft Tissue Infections, and Skin Diseases. The leading clinical trial sponsors are Arpida AG, Motif Bio, and [disabled in preview].
There are ten US patents protecting this investigational drug and one hundred and five international patents.
Summary for Iclaprim
| US Patents | 10 |
| International Patents | 105 |
| US Patent Applications | 54 |
| WIPO Patent Applications | 43 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2015-11-01) |
| Vendors | 34 |
Recent Clinical Trials for Iclaprim
| Title | Sponsor | Phase |
|---|---|---|
| Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1 | Motif Bio | Phase 3 |
| Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2 | Motif Bio | Phase 3 |
| Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia | Arpida AG | Phase 2 |
Clinical Trial Summary for Iclaprim
Top disease conditions for Iclaprim
Top clinical trial sponsors for Iclaprim
US Patents for Iclaprim
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Iclaprim | Start Trial | Diamino pyrimidines | Hoffmann-La Roche Inc. (Nutley, NJ) | Start Trial |
| Iclaprim | Start Trial | Process for the preparation of 2H-chromenes | Arpida AG (Muenchenstein, CH) | Start Trial |
| Iclaprim | Start Trial | Skin-contacting-adhesive free dressing | Start Trial | |
| Iclaprim | Start Trial | Aqueous pharmaceutical formulation | Arpida AG (Reinach, CH) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Iclaprim
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Iclaprim | Austria | 212629 | 2015-12-04 | Start Trial |
| Iclaprim | Australia | 708578 | 2015-12-04 | Start Trial |
| Iclaprim | Australia | 7696396 | 2015-12-04 | Start Trial |
| Iclaprim | Brazil | 9611871 | 2015-12-04 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
